Last update 14 Jun 2025

STX-200

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
alpha-v/beta-5 mAb(Stromedix), alpha-v/beta-5 mAb(University of California San Francisco), alpha-v/beta-5 monoclonal antibody(Stromedix)
+ [2]
Target
CRAF
Action
inhibitors
Mechanism
CRAF inhibitors(C-Raf kinase inhibitors)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesRespiratory Diseases+ [2]
Active Indication-
Inactive Indication
Acute Lung InjuryFibrosisMultiple Organ Failure+ [2]
Originator Organization
The University of California, San FranciscoThe University of California, San Francisco
Active Organization-
Inactive Organization
Stromedix, Inc.Stromedix, Inc.
License Organization-
Drug Highest PhasePendingDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with STX-200
Login to view more data
100 Translational Medicine associated with STX-200
Login to view more data
100 Patents (Medical) associated with STX-200
Login to view more data
1
Literatures (Medical) associated with STX-200
01 Jan 2001Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Correlation of cell apoptosis induction with expression of human beta5 integrin on hematopoietic cells].
100 Deals associated with STX-200
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lung InjuryDiscovery
United States
Stromedix, Inc.Stromedix, Inc.
30 Jun 2011
Scleroderma, SystemicDiscovery
United States
Stromedix, Inc.Stromedix, Inc.
30 Jun 2011
SepsisDiscovery
United States
Stromedix, Inc.Stromedix, Inc.
30 Jun 2011
FibrosisDiscovery
United States
Stromedix, Inc.Stromedix, Inc.
18 Nov 2010
Multiple Organ FailureDiscovery
United States
Stromedix, Inc.Stromedix, Inc.
18 Nov 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free